Dr. Lydia Scarfò is a physician scientist at the B-cell neoplasia Unit and an assistant professor at Università Vita-Salute San Raffaele, Milano, Italy.
June 27, 2025
Video
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
Just Diagnosed? What Stage 1 Oral Cavity Cancer Really Means for You
Body Image and Sexual Health Challenges After Breast Cancer
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
Breast Cancer Awareness Needs Action, Not Just Pink Ribbons